D,
CYT are going to pay you for it, not seal it.
Avx and the BOD are only offering you a share of the costly ph3 with big risk. Its the same situation as they had with ip-88. No partner, to validate the drug the only difference if the drug is spelt ACT not PI-88.
And don’t give me the spin, about “near term value inflection points” and “discussion with several parties” because we have heard it all before.
tell cytopia enough is enough, page-3
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
